Identification and quantification of 30 antipsychotics in blood using LC-MS/MS

Journal of Mass Spectrometry

Volumn 45, Issue 8, 2010, Pages 915-925

  Saar, Eva ^a   Gerostamoulos, Dimitri ^a   Drummer, Olaf H ^a   Beyer, Jochen ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antipsychotics; Blood; Detection; LC MS MS; Quantification

Indexed keywords

AMMONIUM FORMATE; ANTIPSYCHOTICS; APPLIED BIOSYSTEMS; AUTOSAMPLERS; BLOOD SAMPLES; CALIBRATION CURVES; CARDIAC DEATH; DETECTION; INTERNAL STANDARDS; LC-MS/MS; LIQUID-LIQUID EXTRACTION; LOWER LIMITS; MULTIPLE-REACTION MONITORING MODES; PERPHENAZINE; QUANTIFICATION; ROUTINE ANALYSIS; SHIMADZU; SPRAY IONIZATION;

ACETONITRILE; AMMONIUM COMPOUNDS; BLOOD; CALIBRATION; CENTRIFUGATION; FORMIC ACID; ION SOURCES; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; LIQUIDS; ORGANIC ACIDS; PATIENT MONITORING; POPULATION STATISTICS;

SOLVENT EXTRACTION;

ACETONITRILE; AMMONIUM FORMATE; BROMPERIDOL; BUSPIRONE; BUTANE; CHLORPROMAZINE; CHLORPROTHIXENE; DROPERIDOL; FLUPHENAZINE; FLUSPIRILENE; FORMIC ACID; HALOPERIDOL; LOXAPINE; MESORIDAZINE; NEUROLEPTIC AGENT; OLANZAPINE; PERICIAZINE; PERPHENAZINE; PIMOZIDE; PIPAMPERONE; PROCHLORPERAZINE; PROMAZINE; PROMETHAZINE; RISPERIDONE; SOLVENT; THIORIDAZINE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; TROMETAMOL; ZUCLOPENTHIXOL;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CADAVER; CALIBRATION; CENTRIFUGATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; AUTOPSY; BENZODIAZEPINES; BUTYROPHENONES; CALIBRATION; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HALOPERIDOL; HUMANS; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 77955867587     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1783     Document Type: Article

References (24)

1. R. R. Aparasu, V. Bhatara. Antipsychotic prescribing trends among youths, 1997-2002. Psychiatr. Serv. 2005, 56(8), 904.
2. W. O. Cooper, P. G. Arbogast, H. Ding, G. B. Hickson, D. C. Fuchs, W. A. Ray. Trends in prescribing of antipsychotic medications for US children. Ambul. Pediatr. 2006, 6(2), 79.
3. J. A. Kaye, B.D. Bradbury, H. Jick. Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br. J. Clin. Pharmacol. 2003, 56(5), 569.
4. A. Wheeler, V. Humberstone, G. Robinson. Trends in antipsychotic prescribing inschizophrenia in Auckland. Australas. Psychiatry 2006, 14(2), 169.
5. S. M. Straus, G. S. Bleumink, J. P.Dieleman, J. van der Lei, G.W. t Jong, J. H. Kingma, M. C. Sturkenboom, B. H. Stricker. Antipsychotics and the risk of sudden cardiac death. Arch.Intern.Med.2004,164(12), 1293.
6. W. A. Ray, S. Meredith, P. B. Thapa, K. G. Meador, K. Hall, K. T. Murray. Antipsychotics and the risk of sudden cardiac death. Arch. Gen. Psychiatry 2001, 58(12), 1161.
7. W. A. Ray, C. P. Chung, K. T. Murray, K.Hall, C.M. Stein. Atypical antipsychotic drugs and the risk of sudden cardiac death. N. Engl. J. Med. 2009, 360(3), 225.
8. E. Tanaka, T. Nakamura, M. Terada, T. Shinozuka, C. Hashimoto, K. Kurihara, K. Honda. Simple and simultaneous determination for 12 phenothiazines in human serum by reversed-phase high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 854(1-2), 116.
9. L. Mercolini, M. Grillo, C. Bartoletti, G. Boncompagni, M. A. Raggi. Simultaneous analysis of classical neuroleptics, atypical antipsychotics and their metabolites in human plasma. Anal. Bioanal. Chem. 2007, 388(1), 235.
10. K. Titier, S. Bouchet, F. Pehourcq, N. Moore, M. Molimard. High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 788(1), 179.
11. C. Sanchez de la Torre, M. A. Martinez, E. Almarza. Determination of several psychiatric drugs in whole blood using capillary gas-liquid chromatography with nitrogen phosphorus detection: comparison of two solid phase extraction procedures. Forensic Sci. Int. 2005, 155(2-3), 193.
12. H. Kirchherr, W. N. Kuhn-Velten. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006, 843(1), 100.
13. C. Kratzsch, F. T. Peters, T. Kraemer, A. A. Weber, H. H. Maurer. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 2003, 38(3), 283.
14. M. Josefsson, R. Kronstrand, J. Andersson, M. Roman. Evaluation of electrospray ionisation liquid chromatography-tandem mass spectrometry for rationaldetermination of anumberofneuroleptics and their major metabolites in human body fluids and tissues. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 789(1), 151.
15. M. Roman, R. Kronstrand, D. Lindstedt, M. Josefsson. Quantitation of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS-MS. J. Anal. Toxicol. 2008, 32(2), 147.
16. F. T. Peters, H. H. Maurer. Bioanalytical method validation and its implications for forensic and clinical toxicology - a review. Accred Qual Assur 2002, 7(11), 441.
17. F. T. Peters, O. H. Drummer, F. Musshoff. Validation of new methods. Forensic Sci. Int. 2007, 165(2-3), 216.
18. M. Schulz, A. Schmoldt. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003, 58(7), 447.
19. J. Beyer, F. T. Peters, T. Kraemer, H. H. Maurer. Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization. J. Mass Spectrom. 2007, 42(2), 150.
20. J. Beyer, F. T. Peters, T. Kraemer, H. H. Maurer. Detection and validated quantification of toxic alkaloids in human blood plasma-comparison of LC-APCI-MS with LC-ESI-MS/MS. J. Mass Spectrom. 2007, 42(5), 621.
21. V. P. Shah, K. K. Midha, J. W. Findlay, H. M. Hill, J. D. Hulse, I. J. McGilveray, G. McKay, K. J. Miller, R. N. Patnaik, M. L. Powell, A. Tonelli, C. T. Viswanathan, A. Yacobi. Bioanalytical method validation-a revisit with a decade of progress. Pharm. Res. 2000, 17(12), 1551.
22. E. Saar, D. Gerostamoulos, O. H. Drummer, J. Beyer. Comparison of extraction efficiencies and LC-MS-MS matrix effects using LLE and SPE methods for 19 antipsychotics in human blood. Anal. Bioanal. Chem. 2009, 393(2), 727.
23. U. S. Department of Health and Human Services. F. D. A., Guidance for Industry Bioanalytical Method Validation. 2001.
24. H. A. Lakso. Instability of olanzapine in calf serum. Ther. Drug Monit. 2001, 23(4), 454.